Impact of Procalcitonin-guided Algorithm on Early Discontinuation of Antibiotic Therapy

Recruiting N/A Interventional Study
Bacterial Infections
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 Days – 17
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
296 (estimated)
Sponsor
University Hospital, Toulouse · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In this randomized controlled open-label trial, conducted in 7 French Pediatric and Neonatal Intensive Care Units (ICUs), investigator team hypothesize that the use of a procalcitonin (PCT)-guided algorithm to discontinue antibiotic treatment will decrease antibiotic duration in critically ill children treated for a suspected or proven bacterial infection. Two hundred and ninety-six eligible patie…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Neonates, infants and children hospitalized in Pediatric and Neonatal ICU and receiving intravenous antibiotics for less than 24 hours for an episode of suspected or proven community-acquired or nosocomial bacterial infection. * Written informed consent signed by both parents …
Contacts

Montserrat SIERRA COLOMINA, MD

05 61 74 51 45

sierracolomina.m@chu-toulouse.fr

CONTACT

Gwennaëlle ALPHONSA, MD-PH

056-777-1394

alphonsa.g@chu-toulouse.fr

CONTACT